6 hours ago
Mark Cuban, co-founder of Cost Plus Drugs, and Linda Yaccarino, CEO of the employer GLP-1 platform eMed Population Health, appeared at SXSW to highlight how their approach to GLP-1 drugs differs from that of other direct-to-consumer companies. During the event, they also announced a collaboration in which Cost Plus Drugs will serve as eMed's distribution partner.
